title: [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
authors: A
authors: A
authors: Masmoudi
authors: I
authors: I
authors: Hadj-Taieb
authors: T
authors: T
authors: Kammon
authors: M
authors: M
authors: Mseddi
authors: S
authors: S
authors: Boudaya
authors: M
authors: M
authors: Chaabouni
authors: M
authors: M
authors: Hachicha
authors: H
authors: H
authors: Turki
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002780:Cholestasis, Intrahepatic / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D019587:Dietary Supplements; D018450:Disease Progression; D005260:Female; D006801:Humans; D007223:Infant; D012293:Rifampin / Q000627:therapeutic use; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D002756:Cholagogues and Choleretics; D014815:Vitamins; D014580:Ursodeoxycholic Acid; D012293:Rifampin